These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 9226251)
1. Alterations in induced potassium calcium efflux in the erythrocytes of patients with autosomal dominant polycystic kidney disease and hypertension. Buemi M; Allegra A; Marino D; Marino MT; Aloisi C; Casuscelli T; Frisina N; Corica F Nephron; 1997; 76(3):369-70. PubMed ID: 9226251 [No Abstract] [Full Text] [Related]
2. Red blood cell Na(+)-K+ pump activity and arterial hypertension in autosomal dominant polycystic kidney disease. Boero R; Guarena C; Carbone D; Piccoli G Nephron; 1996; 72(2):321. PubMed ID: 8684549 [No Abstract] [Full Text] [Related]
3. Sodium-lithium countertransport in autosomal polycystic kidney disease. Li Vecchi M; Andronico G; Ferrara L; Renda F; Parrino IA; Pavone G; Mulé G; Ferrantelli A; Di Natale E; Cerasola G Contrib Nephrol; 1997; 122():31-4. PubMed ID: 9399034 [No Abstract] [Full Text] [Related]
4. [Common bile duct dilatation: one more complication in patients with autosomal dominant polycystic kidney disease]. Gmar-Bouraoui S; Skhiri S; Achour A; Skhiri H; Ben Dhia N; El May M Ann Med Interne (Paris); 2001 Jun; 152(4):285-6. PubMed ID: 11474380 [No Abstract] [Full Text] [Related]
6. [Sodium, potassium, calcium and magnesium in the erythrocytes of patients with borderline hypertension]. Grzesiuk W; Młynski J; Jabłońska-Skwiecińska E; Lapiński M; Drygieniec D; Staniszewska K Kardiol Pol; 1988; 31 Suppl 2():29-35. PubMed ID: 3244239 [No Abstract] [Full Text] [Related]
7. Native Nephrectomy with Renal Transplantation is Associated with a Decrease in Hypertension Medication Requirements for Autosomal Dominant Polycystic Kidney Disease. Shumate AM; Bahler CD; Goggins WC; Sharfuddin AA; Sundaram CP J Urol; 2016 Jan; 195(1):141-6. PubMed ID: 26318985 [TBL] [Abstract][Full Text] [Related]
8. Increased sodium, potassium cotransport activity in salt-sensitive essential hypertensive patients. Cacciafesta M; Ferri C; Carlomagno A; Piccirillo G; De Angelis C; Santucci A; Guidoni L; Luciani AM; Rosi A; Viti V J Hypertens Suppl; 1993 Dec; 11(5):S254-5. PubMed ID: 8158371 [No Abstract] [Full Text] [Related]
9. Clinical profile of essential hypertensives based on ion transport abnormalities. de la Sierra A; Coca A; Paré JC; Sánchez M; Compte M; Azqueta M; Urbano-Márquez A J Hypertens Suppl; 1993 Dec; 11(5):S250-1. PubMed ID: 8158369 [No Abstract] [Full Text] [Related]
10. Shape of the relationship between hypertension and the rate of progression of renal failure in autosomal dominant polycystic kidney disease. Gonzalo A; Gallego A; Rivera M; Orte L; Ortuño J Nephron; 1992; 62(1):52-7. PubMed ID: 1436292 [TBL] [Abstract][Full Text] [Related]
11. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease. Kocyigit I; Yilmaz MI; Unal A; Ozturk F; Eroglu E; Yazici C; Orscelik O; Sipahioglu MH; Tokgoz B; Oymak O Am J Nephrol; 2013; 38(3):218-25. PubMed ID: 23988725 [TBL] [Abstract][Full Text] [Related]
12. [Role of membrane-bound calcium in the changes of ion permeability and Na+, 5+ and ATPase activity of the erythrocytes in hypertension]. Postnov IuV; Orlov SN; Adler AM Kardiologiia; 1977 Sep; 17(9):111-9. PubMed ID: 144818 [TBL] [Abstract][Full Text] [Related]
13. Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function. Gul CB; Yildiz A; Ersoy A; Kahvecioglu S; Asiltas B; Yildirim F; Ermurat S; Sag S; Oruc A; Gullulu S; Gullulu M Int Urol Nephrol; 2015 Jul; 47(7):1187-94. PubMed ID: 26047596 [TBL] [Abstract][Full Text] [Related]
14. Polycystic kidney disease presenting with hypertension and hypokalemia. Chow KM; Ma RC; Szeto CC; Li PK Am J Kidney Dis; 2012 Feb; 59(2):270-2. PubMed ID: 21962616 [TBL] [Abstract][Full Text] [Related]
15. [Disruption of erythrocyte membrane permeability for sodium and potassium ions in hypertension]. Postnov IuV; Orolov SN; Shevchenko AS; Adler AM; Sidorskiĭ AL Kardiologiia; 1976 Nov; 16(11):65-70. PubMed ID: 1011469 [TBL] [Abstract][Full Text] [Related]
16. [Cation transport in erythrocytes of hypertensive patients: etiopathogenetic and clinical importance]. Greca AA; Alonso HO Medicina (B Aires); 1985; 45(1):81-3. PubMed ID: 3880111 [No Abstract] [Full Text] [Related]
17. Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner. Pietrzak-Nowacka M; Safranow K; Czechowska M; Dutkiewicz G; Kornacewicz-Jach Z; Ciechanowski K Kidney Blood Press Res; 2012; 36(1):301-9. PubMed ID: 23235185 [TBL] [Abstract][Full Text] [Related]
18. New options in the treatment of autosomal dominant polycystic kidney disease. Kazancioglu R; Gursu M Ren Fail; 2015 May; 37(4):535-41. PubMed ID: 25682970 [TBL] [Abstract][Full Text] [Related]
19. Measurement of erythrocyte sodium and calcium efflux kinetics in man, and application to hypertension. Bramley PM; Logan BJ; Millar JA Klin Wochenschr; 1985; 63 Suppl 3():12-5. PubMed ID: 3999628 [No Abstract] [Full Text] [Related]
20. Moxonidine-induced priapism in an autosomal-dominant polycystic kidney disease dialysis patient. Gupta A; Singh B Saudi J Kidney Dis Transpl; 2012 May; 23(3):588-9. PubMed ID: 22569452 [No Abstract] [Full Text] [Related] [Next] [New Search]